Elanco Animal Health Incorporated vs Eli Lilly & Co.
ELAN vs LLY — side-by-side comparison from reported financials. ELAN leads 1, LLY leads 9 of 10 comparable metrics.
Elanco Animal Health Incorporated
ELAN · Healthcare
$22.92+1.69%Mixed
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | ELAN | LLY |
|---|---|---|
| Price | $22.92 | $1 177.20 |
| Market cap | $11.4B | $1.05T |
| Revenue (TTM) | $5.02B | $79.7B |
| Revenue growth | +2.3% | +31.7% |
| Net margin | -4.0% | 33.5% |
| Free cash flow | $379M | $18.2B |
| Net cash (debt) | ($3.47B) | ($35.2B) |
| 1-year price return | +14.2% | +37.6% |
| P/E | — | 41.6 |
| P/E vs own history (cheap-side %) | 14% | 88% |
| Dividend yield | — | 0.52% |
| Return on equity | -3% | 93% |
| Altman Z-score | 1.23 | 7.10 |
| CV checks passed | 3 of 9 | 11 of 9 |
| Employees | 9,900 | 50,000 |
Full résumé-style profiles: ELAN CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.